Immunity and lipid metabolism are intermingled at several levels: both circulating lipoproteins and intracellular lipid metabolism can modulate immune cell functions, especially those of regulatory T cells. In this review, Pinzon Grimaldos et al. explore the available knowledge on the role of lipid metabolism, and cholesterol in particular, in shaping Treg expansion and function. This pathway may become especially relevant in the context of atherosclerotic disease.Metabolic inflammation, defined as a chronic low-grade inflammation, is implicated in numerous metabolic diseases. In recent years, the role of regulatory T cells (Tregs) as key controllers of metabolic inflammation has emerged, but our comprehension on how different metabolic pathways influence Treg functions needs a deeper understanding. Here we focus on how circulating and intracellular lipid metabolism, in particular cholesterol metabolism, regulates Treg homeostasis, expansion, and functions. Cholesterol is carried through the bloodstream by circulating lipoproteins (chylomicrons, very low-density lipoproteins, low-density lipoproteins). Tregs are equipped with a wide array of metabolic sensors able to perceive and respond to changes in the lipid environment through the activation of different intracellular pathways thus conferring to these cells a crucial metabolic and functional plasticity. Nevertheless, altered cholesterol transport, as observed in genetic dyslipidemias and atherosclerosis, impairs Treg proliferation and function through defective cellular metabolism. The intracellular pathway devoted to the cholesterol synthesis is the mevalonate pathway and several studies have shown that this pathway is essential for Treg stability and suppressive activity. High cholesterol concentrations in the extracellular environment may induce massive accumulation of cholesterol inside the cell thus impairing nutrients sensors and inhibiting the mevalonate pathway. This review summarizes the current knowledge regarding the role of circulating and cellular cholesterol metabolism in the regulation of Treg metabolism and functions. In particular, we will discuss how different pathological conditions affecting cholesterol transport may affect cellular metabolism in Tregs.
The role of lipid metabolism in shaping the expansion and the function of regulatory T cells / Pinzon Grimaldos, Alessandra; Bini, Simone; Pacella, Ilenia; Rossi, Alessandra; Di Costanzo, Alessia; Minicocci, Ilenia; D'Erasmo, Laura; Arca, Marcello; Piconese, Silvia. - In: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. - ISSN 0009-9104. - 208:2(2022), pp. 181-192. [10.1093/cei/uxab033]
The role of lipid metabolism in shaping the expansion and the function of regulatory T cells
Pinzon Grimaldos, Alessandra;Bini, Simone;Pacella, Ilenia;Rossi, Alessandra;Di Costanzo, Alessia;Minicocci, Ilenia;D'Erasmo, Laura;Arca, Marcello;Piconese, Silvia
2022
Abstract
Immunity and lipid metabolism are intermingled at several levels: both circulating lipoproteins and intracellular lipid metabolism can modulate immune cell functions, especially those of regulatory T cells. In this review, Pinzon Grimaldos et al. explore the available knowledge on the role of lipid metabolism, and cholesterol in particular, in shaping Treg expansion and function. This pathway may become especially relevant in the context of atherosclerotic disease.Metabolic inflammation, defined as a chronic low-grade inflammation, is implicated in numerous metabolic diseases. In recent years, the role of regulatory T cells (Tregs) as key controllers of metabolic inflammation has emerged, but our comprehension on how different metabolic pathways influence Treg functions needs a deeper understanding. Here we focus on how circulating and intracellular lipid metabolism, in particular cholesterol metabolism, regulates Treg homeostasis, expansion, and functions. Cholesterol is carried through the bloodstream by circulating lipoproteins (chylomicrons, very low-density lipoproteins, low-density lipoproteins). Tregs are equipped with a wide array of metabolic sensors able to perceive and respond to changes in the lipid environment through the activation of different intracellular pathways thus conferring to these cells a crucial metabolic and functional plasticity. Nevertheless, altered cholesterol transport, as observed in genetic dyslipidemias and atherosclerosis, impairs Treg proliferation and function through defective cellular metabolism. The intracellular pathway devoted to the cholesterol synthesis is the mevalonate pathway and several studies have shown that this pathway is essential for Treg stability and suppressive activity. High cholesterol concentrations in the extracellular environment may induce massive accumulation of cholesterol inside the cell thus impairing nutrients sensors and inhibiting the mevalonate pathway. This review summarizes the current knowledge regarding the role of circulating and cellular cholesterol metabolism in the regulation of Treg metabolism and functions. In particular, we will discuss how different pathological conditions affecting cholesterol transport may affect cellular metabolism in Tregs.File | Dimensione | Formato | |
---|---|---|---|
Pinzon_The-role_2022.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
1.3 MB
Formato
Adobe PDF
|
1.3 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.